A Dutch hospital reported stopping a clinical trial after the deaths of 11 babies whose mothers were taking generic Viagra.

The purpose of the trial was to determine whether sildenafil, commonly sold under the brand name Viagra, could help improve placental function and stimulate growth in severely underdeveloped babies.

The trial began in 2015, involving 183 mothers in 11 hospitals in the Netherlands, according to the University Medical Center in Amsterdam. In the trial, 93 mothers were treated with Viagra, while another 90 received a placebo.

The results found 11 babies whose mothers were treated with sildenafil died of a form of high blood pressure in the lungs. In the control group, three babies had lung disease, but none of them died.

"Previous studies have shown that sildenafil has a positive effect on the growth of babies," said the medical center. "The first results of the present study showed that there could be adverse effects for the baby after birth."

In a statement, Pfizer, makers of Viagra, said that they were not involved in the lawsuit.

A similar study conducted in the UK to test the efficacy of sildenafil has not shown any benefit to pregnant women, reports CNN, but revealed no effects undesirable effects of the Dutch test. [19659006"Cetteconstatationdansl'étudenéerlandaiseestinattendue"expliqueZarckoAlfirevicprofesseuràl'UniversitédeLiverpooletl'undesauteurscitésdansl'étudebritanniqueàlaBBC"NousdevonsêtreprudentsàcestadepourensavoirpluscarilfautmeneruneenquêteapprofondiecarlesdeuxautresessaissimilairesquiontdéjàétéeffectuésauRoyaume-UnienAustralieetenNouvelle-Zélandenemontrentaucunecomplication"

Follow Brett Molina on Twitter: @ brettmolina23 .

Read or share this story: https://usat.ly/2NIYHTJ